Summit Therapeutics IncNASDAQ:SMMT
- LAST PRICE4.3900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.4500/ 2
- Ask / Lots4.5200/ 6
- Open / Previous Close4.5000 / 4.3900
- Day Range
- 52 Week Range
- Volume1,191,776
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SMMT |
|---|---|---|
| 09:32 ET | 20565 | 4.43 |
| 09:34 ET | 3043 | 4.38 |
| 09:36 ET | 4300 | 4.37 |
| 09:38 ET | 4900 | 4.42 |
| 09:39 ET | 400 | 4.4 |
| 09:41 ET | 906 | 4.37 |
| 09:43 ET | 1100 | 4.37 |
| 09:45 ET | 11302 | 4.35 |
| 09:48 ET | 16393 | 4.31 |
| 09:50 ET | 16345 | 4.385 |
| 09:52 ET | 1565 | 4.39 |
| 09:54 ET | 650 | 4.39 |
| 09:56 ET | 2328 | 4.3646 |
| 09:57 ET | 600 | 4.36 |
| 09:59 ET | 700 | 4.355 |
| 10:01 ET | 100 | 4.355 |
| 10:03 ET | 3325 | 4.38 |
| 10:06 ET | 1815 | 4.3852 |
| 10:08 ET | 2741 | 4.38 |
| 10:10 ET | 1838 | 4.365 |
| 10:12 ET | 2887 | 4.365 |
| 10:14 ET | 3239 | 4.385 |
| 10:15 ET | 1758 | 4.38 |
| 10:17 ET | 1306 | 4.375 |
| 10:19 ET | 3784 | 4.415 |
| 10:21 ET | 6071 | 4.43 |
| 10:24 ET | 838 | 4.445 |
| 10:26 ET | 850 | 4.445 |
| 10:28 ET | 2679 | 4.445 |
| 10:30 ET | 2711 | 4.45 |
| 10:32 ET | 2704 | 4.465 |
| 10:33 ET | 7489 | 4.49 |
| 10:35 ET | 5723 | 4.51 |
| 10:37 ET | 2864 | 4.48 |
| 10:39 ET | 7659 | 4.48 |
| 10:42 ET | 3000 | 4.46 |
| 10:44 ET | 100 | 4.47 |
| 10:46 ET | 10971 | 4.42 |
| 10:48 ET | 30406 | 4.405 |
| 10:50 ET | 600 | 4.41 |
| 10:51 ET | 589 | 4.415 |
| 10:53 ET | 831 | 4.415 |
| 10:55 ET | 4363 | 4.405 |
| 10:57 ET | 5866 | 4.395 |
| 11:00 ET | 1100 | 4.405 |
| 11:02 ET | 901 | 4.39 |
| 11:04 ET | 6198 | 4.36 |
| 11:06 ET | 2910 | 4.355 |
| 11:08 ET | 2860 | 4.3649 |
| 11:09 ET | 450 | 4.365 |
| 11:11 ET | 200 | 4.36 |
| 11:13 ET | 10780 | 4.365 |
| 11:15 ET | 9345 | 4.34 |
| 11:18 ET | 12795 | 4.35 |
| 11:20 ET | 13854 | 4.34 |
| 11:22 ET | 3666 | 4.37 |
| 11:24 ET | 3350 | 4.395 |
| 11:26 ET | 7392 | 4.39 |
| 11:27 ET | 4606 | 4.385 |
| 11:29 ET | 3400 | 4.375 |
| 11:31 ET | 1300 | 4.3812 |
| 11:33 ET | 2550 | 4.405 |
| 11:36 ET | 2467 | 4.405 |
| 11:38 ET | 2369 | 4.4 |
| 11:40 ET | 8518 | 4.385 |
| 11:42 ET | 881 | 4.385 |
| 11:44 ET | 2022 | 4.38 |
| 11:45 ET | 300 | 4.375 |
| 11:47 ET | 820 | 4.375 |
| 11:49 ET | 907 | 4.385 |
| 11:51 ET | 4301 | 4.38 |
| 11:54 ET | 500 | 4.39 |
| 11:56 ET | 100 | 4.39 |
| 11:58 ET | 3887 | 4.39 |
| 12:00 ET | 2350 | 4.385 |
| 12:02 ET | 700 | 4.395 |
| 12:03 ET | 3607 | 4.395 |
| 12:05 ET | 1390 | 4.415 |
| 12:07 ET | 8534 | 4.425 |
| 12:09 ET | 8776 | 4.405 |
| 12:12 ET | 400 | 4.42 |
| 12:14 ET | 1512 | 4.41 |
| 12:16 ET | 709 | 4.42 |
| 12:18 ET | 400 | 4.415 |
| 12:20 ET | 449 | 4.405 |
| 12:21 ET | 1581 | 4.415 |
| 12:23 ET | 300 | 4.415 |
| 12:25 ET | 1667 | 4.4051 |
| 12:27 ET | 1639 | 4.39 |
| 12:30 ET | 400 | 4.395 |
| 12:32 ET | 428 | 4.395 |
| 12:34 ET | 300 | 4.39 |
| 12:36 ET | 2709 | 4.38 |
| 12:38 ET | 1455 | 4.385 |
| 12:39 ET | 3100 | 4.385 |
| 12:41 ET | 349 | 4.385 |
| 12:43 ET | 4767 | 4.385 |
| 12:45 ET | 1075 | 4.3805 |
| 12:48 ET | 4530 | 4.365 |
| 12:50 ET | 5624 | 4.365 |
| 12:52 ET | 1000 | 4.36 |
| 12:54 ET | 1200 | 4.365 |
| 12:56 ET | 238 | 4.365 |
| 12:57 ET | 189 | 4.365 |
| 12:59 ET | 600 | 4.365 |
| 01:01 ET | 100 | 4.37 |
| 01:03 ET | 1650 | 4.38 |
| 01:06 ET | 1248 | 4.38 |
| 01:08 ET | 1252 | 4.381 |
| 01:10 ET | 344 | 4.385 |
| 01:12 ET | 4853 | 4.39 |
| 01:14 ET | 300 | 4.39 |
| 01:15 ET | 2833 | 4.385 |
| 01:17 ET | 200 | 4.4 |
| 01:19 ET | 500 | 4.39 |
| 01:21 ET | 565 | 4.39 |
| 01:24 ET | 845 | 4.385 |
| 01:26 ET | 665 | 4.39 |
| 01:28 ET | 222 | 4.385 |
| 01:30 ET | 749 | 4.385 |
| 01:32 ET | 2863 | 4.37 |
| 01:33 ET | 100 | 4.365 |
| 01:35 ET | 5275 | 4.375 |
| 01:37 ET | 1393 | 4.3547 |
| 01:39 ET | 1833 | 4.36 |
| 01:42 ET | 1674 | 4.35 |
| 01:44 ET | 1096 | 4.355 |
| 01:46 ET | 100 | 4.355 |
| 01:48 ET | 645 | 4.365 |
| 01:50 ET | 300 | 4.37 |
| 01:53 ET | 2133 | 4.365 |
| 01:55 ET | 2130 | 4.35 |
| 01:57 ET | 853 | 4.345 |
| 02:00 ET | 3321 | 4.3501 |
| 02:02 ET | 6024 | 4.35 |
| 02:04 ET | 6834 | 4.325 |
| 02:06 ET | 2580 | 4.33 |
| 02:08 ET | 3137 | 4.315 |
| 02:09 ET | 328 | 4.31 |
| 02:11 ET | 1959 | 4.33 |
| 02:13 ET | 1940 | 4.32 |
| 02:15 ET | 200 | 4.32 |
| 02:18 ET | 11925 | 4.325 |
| 02:20 ET | 1400 | 4.32 |
| 02:22 ET | 4320 | 4.315 |
| 02:24 ET | 2006 | 4.33 |
| 02:26 ET | 585 | 4.34 |
| 02:27 ET | 822 | 4.335 |
| 02:29 ET | 3306 | 4.335 |
| 02:31 ET | 857 | 4.34 |
| 02:33 ET | 2075 | 4.335 |
| 02:36 ET | 618 | 4.33 |
| 02:38 ET | 1400 | 4.315 |
| 02:42 ET | 285 | 4.315 |
| 02:44 ET | 1536 | 4.32 |
| 02:45 ET | 5209 | 4.339 |
| 02:47 ET | 584 | 4.335 |
| 02:49 ET | 721 | 4.34 |
| 02:51 ET | 1375 | 4.34 |
| 02:54 ET | 1815 | 4.335 |
| 02:56 ET | 2038 | 4.325 |
| 02:58 ET | 710 | 4.335 |
| 03:00 ET | 475 | 4.335 |
| 03:02 ET | 1186 | 4.35 |
| 03:03 ET | 857 | 4.3599 |
| 03:05 ET | 18407 | 4.37 |
| 03:07 ET | 951 | 4.365 |
| 03:09 ET | 18152 | 4.36 |
| 03:12 ET | 3200 | 4.355 |
| 03:14 ET | 15012 | 4.345 |
| 03:16 ET | 100 | 4.34 |
| 03:18 ET | 1285 | 4.345 |
| 03:20 ET | 3696 | 4.32 |
| 03:21 ET | 925 | 4.325 |
| 03:23 ET | 2534 | 4.3349 |
| 03:25 ET | 2012 | 4.325 |
| 03:27 ET | 907 | 4.325 |
| 03:30 ET | 3872 | 4.325 |
| 03:32 ET | 1887 | 4.34 |
| 03:34 ET | 1086 | 4.34 |
| 03:36 ET | 12180 | 4.32 |
| 03:38 ET | 3605 | 4.325 |
| 03:39 ET | 763 | 4.33 |
| 03:41 ET | 5444 | 4.325 |
| 03:43 ET | 3433 | 4.34 |
| 03:45 ET | 5773 | 4.335 |
| 03:48 ET | 11614 | 4.36 |
| 03:50 ET | 5244 | 4.35 |
| 03:52 ET | 6828 | 4.335 |
| 03:54 ET | 9390 | 4.342 |
| 03:56 ET | 26083 | 4.38 |
| 03:57 ET | 24957 | 4.39 |
| 03:59 ET | 49712 | 4.39 |
May 7, 2024
DJ Summit Therapeutics Initiated at Buy by Citigroup, from 8:27AM ET on Tuesday May 07, 2024 by Dow Jones
8:27AM ET on Tuesday May 07, 2024 by Dow Jones
May 1, 2024
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones*DJ Summit Therapeutics 1Q Loss/Shr 6c >SMMT, from 7:00AM ET on Wednesday May 01, 2024 by Dow Jones
7:00AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
Press Release: Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:46PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:46PM ET on Wednesday Apr 24, 2024 by Dow JonesSummit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024, from 4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:30PM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Summit Therapeutics Inc | 3.1B | -26.5x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
SpringWorks Therapeutics Inc | 3.2B | -8.6x | --- |
Xenon Pharmaceuticals Inc | 2.9B | -14.3x | --- |
IDEAYA Biosciences Inc | 3.1B | -20.7x | --- |
Iovance Biotherapeutics Inc | 2.9B | -5.7x | --- |
Company Information
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Contact Information
- Headquarters
- 2882 Sand Hill Road, Suite 106MENLO PARK, CA, United States 94025
- Phone
- 650-460-8308
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Chief Executive Officer
- Robert Duggan
- President, Co-Chief Executive Officer, Director
- Mahkam Zanganeh
- Chief Financial Officer
- Ankur Dhingra
- Chief Operating Officer, Director
- Manmeet Soni
- Lead Non-Executive Independent Director
- Kenneth Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-0.17 |
Book Value | $0.11 |
P/E Ratio | -26.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
